Skip to main content
PDUFA date for Salix's Plenvu extended by FDA

The action date for Salix Pharmaceuticals' marketing application for Plenvu was moved by the FDA to May 13 because the agency needs more time to evaluate additional data the company submitted. The drug is being assessed for bowel cleansing.

Full Story: